Journal of Clinical & Experimental Dermatology Research
Open Access
ISSN: 2155-9554
+44 1478 350008
ISSN: 2155-9554
+44 1478 350008
James J Brennan
Institute of Technology, Ireland
Posters & Accepted Abstracts: Clin Exp Dermatol Res
The Institute of Technology, Sligo (ITS) has developed a novel, patented technology for the topical treatment of onychomycosis. It is a highly efficaceous therapeutic as evidenced through pre-clinical studies which contains a proprietary, synthetic antimicrobial ingredient that is slowly released, penetrating the nail surface to kill the fungus throughout the nail place and bed, eradicating the fungal infection. The antifungal activity in ITS��?s technology differs from current solutions in several ways. First, the antifungal activity has a very small molecular weight and size that allows it to easily penetrate through the nail to kill the fungal infection underneath. Second, the antimicrobial is continuously released over a period of time to more effectively kill the fungal infection. Finally, the technology is a very broad spectrum antimicrobial that has successfully killed all microorganisms tested to date. The technology can be formulated into a broad range of forms including gels, lacquers and thin film delivery systems enabling many standard and novel methods of application.
Email: brennan.james@itsligo.ie